Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Accepts New Drug Application for KPI-121 0.25%

americanpharmaceuticalreviewDecember 29, 2018

Tag: FDA , KPI-121 , drug application , Kala Pharmaceuticals

PharmaSources Customer Service